A single-center, single-arm, prospective, phase IV to determine impact of a rapid ART initiation in advanced HIV disease
Latest Information Update: 07 Sep 2022
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 07 Sep 2022 New trial record
- 02 Aug 2022 Results presented at the 24th International AIDS Conference